Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Behlke

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Oligonucleotides|November 26, 2008
Chemical modification of siRNAs for in vivo useMark A Behlke
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 17, 2006
Progress towards in vivo use of siRNAsMark A Behlke
Methods in Molecular Biology (Clifton, N.J.)|September 1, 2020
Tips for Successful lncRNA Knockdown Using GapmersKim A Lennox, Mark A Behlke
Nucleic Acid Therapeutics|May 21, 2019
Evaluation and Reduction of CRISPR Off-Target Cleavage EventsChristopher A Vakulskas, Mark A Behlke
Current Opinion in Molecular Therapeutics|April 27, 2007
Design of active small interfering RNAsAndrew S Peek, Mark A Behlke
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2011
Progress toward in vivo use of siRNAs-IIGarrett R Rettig, Mark A Behlke
Nucleic Acids Research|November 19, 2015
Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotidesKim A Lennox, Mark A Behlke
Methods in Molecular Biology (Clifton, N.J.)|February 2, 2020
Chemical Modifications in RNA Interference and CRISPR/Cas Genome Editing ReagentsKim A Lennox, Mark A Behlke
Pharmaceutical Research|April 29, 2010
A direct comparison of anti-microRNA oligonucleotide potencyKim A Lennox, Mark A Behlke
Nucleic Acids Research|April 3, 2003
Hybridization of 2'-O-methyl and 2'-deoxy molecular beacons to RNA and DNA targetsAndrew Tsourkas, Mark A Behlke, Gang Bao
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Oligonucleotides|November 26, 2008
Chemical modification of siRNAs for in vivo useMark A Behlke
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 17, 2006
Progress towards in vivo use of siRNAsMark A Behlke
Methods in Molecular Biology (Clifton, N.J.)|September 1, 2020
Tips for Successful lncRNA Knockdown Using GapmersKim A Lennox, Mark A Behlke
Nucleic Acid Therapeutics|May 21, 2019
Evaluation and Reduction of CRISPR Off-Target Cleavage EventsChristopher A Vakulskas, Mark A Behlke
Current Opinion in Molecular Therapeutics|April 27, 2007
Design of active small interfering RNAsAndrew S Peek, Mark A Behlke
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2011
Progress toward in vivo use of siRNAs-IIGarrett R Rettig, Mark A Behlke
Nucleic Acids Research|November 19, 2015
Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotidesKim A Lennox, Mark A Behlke
Methods in Molecular Biology (Clifton, N.J.)|February 2, 2020
Chemical Modifications in RNA Interference and CRISPR/Cas Genome Editing ReagentsKim A Lennox, Mark A Behlke
Pharmaceutical Research|April 29, 2010
A direct comparison of anti-microRNA oligonucleotide potencyKim A Lennox, Mark A Behlke
Nucleic Acids Research|April 3, 2003
Hybridization of 2'-O-methyl and 2'-deoxy molecular beacons to RNA and DNA targetsAndrew Tsourkas, Mark A Behlke, Gang Bao
Pageof 14